Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Subscribe

Sci. Signal., 6 April 2010
Vol. 3, Issue 116, p. pe13
[DOI: 10.1126/scisignal.3116pe13]

PERSPECTIVES

A Trojan Horse for Parkinson’s Disease

Yi Hu* and Youren Tong

Center for Neurologic Diseases, Brigham and Women’s Hospital, Harvard Medical School, 65 Landsdowne Street, Cambridge, MA 02139, USA.

Abstract: Pathogenic mutations in leucine-rich repeat kinase 2 (LRRK2) are common genetic causes of late-onset Parkinson’s disease (PD). Initial studies indicated that the intrinsic kinase activity of LRRK2 is associated with LRRK2-mediated PD pathogenesis. However, LRRK2 kinase activity may be dispensable for neuron survival and may not be required for its protective activity against neurotoxicity. Thus, the intrinsic kinase activity of LRRK2 appears to be a Trojan horse for PD, and inhibition of its kinase activity could potentially be therapeutically beneficial.

* Corresponding author. E-mail: yi_hu{at}hms.harvard.edu

Citation: Y. Hu, Y. Tong, A Trojan Horse for Parkinson’s Disease. Sci. Signal. 3, pe13 (2010).

Read the Full Text



To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882